Xten protein polymer as clinically validated PEG alternative

Dr. Volker Schellenberger of Amunix joined us for Americas Antibody Congress 2016 to discuss ‘ Xten protein polymer as clincially validated PEG alternative’.

In this presentation, learn about Xten protein polymer, and its use as high DAR drug linker and for tumor-protease triggered T cell activation .

Download this presentation to understand more about:

  • Biodegradable polymer with precisely-controlled structure
  • Xten: a homogeneous polymer
  • Evolution of ADC technology

and much more !

Get your copy here !

If you’re interested in learning more about the evolution of ADC technology, join us at Americas Antibody Congress 2017 , held May 23-24 in San Diego, CA . This event is co-located with World Biosimilar Congress USA and Cell Culture World Congress USA.

Learn more about Americas Antibody Congress

Learn more about Americas Antibody Congress